0001235802-24-000014.txt : 20240123
0001235802-24-000014.hdr.sgml : 20240123
20240123161231
ACCESSION NUMBER: 0001235802-24-000014
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20240122
FILED AS OF DATE: 20240123
DATE AS OF CHANGE: 20240123
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lorianne Masuoka K.
CENTRAL INDEX KEY: 0001466086
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36291
FILM NUMBER: 24552610
MAIL ADDRESS:
STREET 1: C/O NEKTAR THERAPEUTICS
STREET 2: 201 INDUSTRIAL ROAD
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DiaMedica Therapeutics Inc.
CENTRAL INDEX KEY: 0001401040
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: Z4
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 CARLSON PARKWAY
STREET 2: SUITE 210
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55305
BUSINESS PHONE: (763) 496-5454
MAIL ADDRESS:
STREET 1: 301 CARLSON PARKWAY
STREET 2: SUITE 210
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55305
FORMER COMPANY:
FORMER CONFORMED NAME: DiaMedica Inc.
DATE OF NAME CHANGE: 20070525
3
1
primary_doc.xml
PRIMARY DOCUMENT
X0206
3
2024-01-22
1
0001401040
DiaMedica Therapeutics Inc.
DMAC
0001466086
Lorianne Masuoka K.
301 CARLSON PARKWAY, SUITE 210
MINNEAPOLIS
MN
55305
0
1
0
0
Chief Medical Officer
Exhibit List - Exhibit No. 24 - Power of Attorney
/s/ Amy E. Culbert, attorney-in-fact
2024-01-23
EX-24
2
masuoka.txt
POWER OF ATTORNEY
POWER OF ATTORNEY
LORIANNE MASUOKA, M.D.
With respect to holdings of and transactions in securities
issued by DiaMedica Therapeutics Inc. (the Company), the
undersigned hereby constitutes and appoints the officers
of the Company listed on Schedule A attached hereto and as
may be amended from time to time, or any of them signing
singly, with full power of substitution and resubstitution,
to act as the undersigned's true and lawful attorney-in-fact
to:
1. execute for and on behalf of the undersigned, Forms 3,
4, and 5 in accordance with Section 16 of the United States
Securities Exchange Act of 1934, as amended, and any Form 144
in accordance with Rule 144 under the Securities Act of 1933,
as amended, and the rules and regulations thereunder;
2. do and perform any and all acts for and on behalf
of the undersigned which may be necessary or desirable to
complete and execute any such Form 3, 4, or 5 or Form 144
or complete and execute any amendment or amendments thereto,
and timely file such forms with the United States Securities
and Exchange Commission (the SEC) and any stock exchange or
similar authority;
3. appoint Deanna Counsell to be the point of contact for
the undersigned's SEC EDGAR filing codes; and
4. take any other action of any type whatsoever in
connection with the foregoing which, in the opinion of
such attorney-in-fact, may be of benefit to, in the best
interest of, or legally required by, the undersigned, it
being understood that the documents executed by such
attorney-in-fact on behalf of the undersigned pursuant
to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact
may approve in the discretion of such attorney-in-fact.
The undersigned hereby grants to each such attorney-in-fact
full power and authority to do and perform any and every act
and thing whatsoever requisite, necessary, or proper to be
done in the exercise of any of the rights and powers herein
granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with
full power of substitution and resubstitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact,
or such attorney-in-fact's substitute or substitutes, shall
lawfully do or cause to be done by virtue of this Power of
Attorney and the rights and powers herein granted.
The undersigned hereby acknowledges that the attorneys-in-fact,
in serving in such capacity at the request of the undersigned,
are not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 of
the United States Securities Exchange Act of 1934, as amended,
or Rule 144 of the Securities Act of 1933, as amended, and any
similar law, rule or regulation.
This Power of Attorney shall remain in full force and effect
until the undersigned is no longer required to file Forms
3, 4, and 5 and Forms 144 with respect to the undersigned's
holdings of and transactions in securities issued by the
Company, unless earlier revoked by the undersigned in a
signed writing delivered to the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power
of Attorney to be executed as of this 22nd day of January
2024.
/s/ Lorianne Masuoka
LORIANNE MASUOKA, M.D.
--------------------------------------------------------
Shedule A
Individuals Appointed as Attorney-in-Fact with Full Power
of Substitution and Resubstitution
1. Rick Pauls, President and Chief Executive Officer
2. Scott Kellen, Chief Financial Officer and Secretary
3. Amy Culbert
4. Emily Humbert
5. Deanna Counsell